Argenx Se (ARGX) Invested Capital (2015 - 2018)
Argenx Se (ARGX) posted quarterly Invested Capital of $31.2 million for Q2 2018, up 40.98% on a QoQ basis from $22.1 million in Q4 2017.
Argenx Se (ARGX) Invested Capital (2015 - 2018) Analysis & Trends
Argenx Se (ARGX) has reported Invested Capital for 4 consecutive years, with $31.2 million the latest figure, recorded in Q2 2018.
- Quarterly Invested Capital changed N/A year-over-year to $31.2 million in Q2 2018, while the trailing twelve-month figure through Mar 2019 was $31.2 million (up 40.98% YoY) and the FY2017 annual result came in at $22.1 million, up 25.57% from the prior year.
- Invested Capital advanced to $31.2 million in Q2 2018 per ARGX's latest filing, from $22.1 million in the prior quarter.
- Over the last five years, Invested Capital for ARGX reached as high as $31.2 million in Q2 2018 and fell as low as $6.6 million in Q4 2015.
- A 4-year average of $19.3 million and a median of $19.8 million in 2017 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2016 — Invested Capital surged 168.37% — and 2017, when it rose 25.57%.
- Year by year, Invested Capital stood at $6.6 million in 2015, then jumped by 168.37% to $17.6 million in 2016, then increased by 25.57% to $22.1 million in 2017, then soared by 40.98% to $31.2 million in 2018.
- According to Business Quant data, Invested Capital over the past three periods registered $31.2 million, $22.1 million, and $17.6 million for Q2 2018, Q4 2017, and Q4 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 31.15 Mn |
| Dec 31, 2017 | 22.10 Mn |
| Dec 31, 2016 | 17.60 Mn |
| Dec 31, 2015 | 6.56 Mn |